InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3063% above fair value
$9.42−0.16 (-1.67%)
Close on Nov 17, 2026Market cap $1.29BP/E –Yield –
InnovAge r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for InnovAge
InnovAge has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?